Krebs Biochem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
57.34
0.62 (1.09%)
BSENSE

Nov 20

BSE+NSE Vol: 2.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 142337,
    "name": "Krebs Biochem",
    "stock_name": "Krebs Biochem",
    "full_name": "Krebs Biochemicals & Industries Ltd",
    "name_url": "stocks-analysis/krebs-biochem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "57.34",
    "chg": 0.62,
    "chgp": "1.09%",
    "dir": 1,
    "prev_price": "56.72",
    "mcapval": "123.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524518,
    "symbol": "KREBSBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE268B01013",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.42 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/krebs-biochem-142337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Krebs Biochemicals & Industries Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-downgraded-to-sell-amid-mixed-technicals-and-weak-fundamentals-4264782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KrebsBiochemica_mojoScore_4264782.png",
        "date": "2026-11-17 08:31:28",
        "description": "Krebs Biochemicals & Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 16 Nov 2026, driven primarily by improvements in technical indicators despite persistent fundamental weaknesses. The company’s micro-cap status and challenging financial trends continue to weigh on its outlook, but recent technical signals have prompted a more favourable stance from analysts."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Forms Golden Cross Amid Mixed Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4264362",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/KrebsBiochemica_goldencross_4264362.png",
        "date": "2026-11-16 18:00:11",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Krebs Biochemicals & Industries Ltd, signalling a golden cross on 16 Nov 2026. Yet, the stock’s modest 0.20% gain on the day and a patchwork of technical indicators suggest the signal is far from straightforward — is this a genuine shift in momentum or a lone signal amid mixed evidence?"
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4245411",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/KrebsBiochemica_mojoScore_4245411.png",
        "date": "2026-10-31 10:10:13",
        "description": "Krebs Biochemicals & Industries Ltd is rated 'Strong Sell' by MarketsMOJO, a rating that was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 31 October 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4219935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/KrebsBiochemica_mojoScore_4219935.png",
        "date": "2026-10-09 10:10:40",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall market standing."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4207079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KrebsBiochemica_mojoScore_4207079.png",
        "date": "2026-09-28 10:10:37",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 September 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4194953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KrebsBiochemica_mojoScore_4194953.png",
        "date": "2026-09-16 10:10:36",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4179527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/KrebsBiochemica_mojoScore_4179527.png",
        "date": "2026-09-02 10:10:26",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the company's current position as of 02 September 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 44,
    "sid": "142337",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/krebs-biochemicals-industries-142337"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Oct-2026",
      "details": "The Company has enclosed herewith copy of newspaper advertiement for financial results for the quarter ended 30.09.2026",
      "source": "BSE"
    },
    {
      "caption": "Result For The Quarter Ended 30.09.2026",
      "datetime": "29-Oct-2026",
      "details": "Financial Results for the quarter ended 30.09.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 29.10.2026",
      "datetime": "29-Oct-2026",
      "details": "Outcome of the Board Meeting for consideration of unaudited financial results for the quarter ended 30.09.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Krebs Biochemicals & Industries Ltd has announced <strong>21:100</strong> rights issue, ex-date: 31 Jan 19",
          "dt": "2019-01-31",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

30-Oct-2026 | Source : BSE

The Company has enclosed herewith copy of newspaper advertiement for financial results for the quarter ended 30.09.2026

Result For The Quarter Ended 30.09.2026

29-Oct-2026 | Source : BSE

Financial Results for the quarter ended 30.09.2026

Board Meeting Outcome for Outcome Of Board Meeting Held On 29.10.2026

29-Oct-2026 | Source : BSE

Outcome of the Board Meeting for consideration of unaudited financial results for the quarter ended 30.09.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19